Intercept Pharmaceuticals Statistics
Total Valuation
ICPT has a market cap or net worth of $794.36 million. The enterprise value is $694.58 million.
| Market Cap | 794.36M |
| Enterprise Value | 694.58M |
Important Dates
The last earnings date was Friday, November 17, 2023, before market open.
| Earnings Date | Nov 17, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ICPT has 41.81 million shares outstanding. The number of shares has increased by 21.87% in one year.
| Shares Outstanding | 41.81M |
| Shares Change (YoY) | +21.87% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 3.13% |
| Owned by Institutions (%) | 81.30% |
| Float | 36.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.21 |
| PS Ratio | 2.50 |
| Forward PS | 2.18 |
| PB Ratio | 11.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.69 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 3.12.
| Current Ratio | 4.22 |
| Quick Ratio | 3.92 |
| Debt / Equity | 3.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.02 |
Financial Efficiency
Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -20.75%.
| Return on Equity (ROE) | -82.20% |
| Return on Assets (ROA) | -12.70% |
| Return on Capital (ROIC) | -20.75% |
| Revenue Per Employee | $931,625 |
| Profits Per Employee | -$180,680 |
| Employee Count | 341 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 0.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.06% in the last 52 weeks. The beta is 0.88, so ICPT's price volatility has been lower than the market average.
| Beta (1Y) | 0.88 |
| 52-Week Price Change | +23.06% |
| 50-Day Moving Average | 15.98 |
| 200-Day Moving Average | 14.74 |
| Relative Strength Index (RSI) | 75.79 |
| Average Volume (30 Days) | 2,127,909 |
Short Selling Information
The latest short interest is 10.19 million, so 24.37% of the outstanding shares have been sold short.
| Short Interest | 10.19M |
| Short Previous Month | 9.43M |
| Short % of Shares Out | 24.37% |
| Short % of Float | 27.77% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, ICPT had revenue of $317.68 million and -$61.61 million in losses. Loss per share was -$2.18.
| Revenue | 317.68M |
| Gross Profit | 317.05M |
| Operating Income | -61.36M |
| Pretax Income | -61.61M |
| Net Income | -61.61M |
| EBITDA | -50.77M |
| EBIT | -51.38M |
| Loss Per Share | -$2.18 |
Balance Sheet
The company has $323.63 million in cash and $223.86 million in debt, giving a net cash position of $99.78 million or $2.39 per share.
| Cash & Cash Equivalents | 323.63M |
| Total Debt | 223.86M |
| Net Cash | 99.78M |
| Net Cash Per Share | $2.39 |
| Equity / Book Value | 71.85M |
| Book Value Per Share | 1.72 |
| Working Capital | 292.60M |
Cash Flow
In the last 12 months, operating cash flow was -$63.02 million and capital expenditures $186,000, giving a free cash flow of -$62.83 million.
| Operating Cash Flow | -63.02M |
| Capital Expenditures | 186,000 |
| Free Cash Flow | -62.83M |
| FCF Per Share | -$1.50 |
Margins
Gross margin is 99.80%, with operating and profit margins of -19.31% and -19.39%.
| Gross Margin | 99.80% |
| Operating Margin | -19.31% |
| Pretax Margin | -19.39% |
| Profit Margin | -19.39% |
| EBITDA Margin | -15.98% |
| EBIT Margin | -16.17% |
| FCF Margin | -19.78% |
Dividends & Yields
ICPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.87% |
| Shareholder Yield | -21.87% |
| Earnings Yield | -7.76% |
| FCF Yield | -7.91% |
Analyst Forecast
The average price target for ICPT is $22.50, which is 18.42% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.50 |
| Price Target Difference | 18.42% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 4.42% |
| EPS Growth Forecast (5Y) | -24.16% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ICPT has an Altman Z-Score of -5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5 |
| Piotroski F-Score | 3 |